The following centres are able to provide chimeric antigen receptor T-cell (CAR-T) therapy for acute lymphoblastic leukaemia for children and young people up to the age of 25:<\/p>
- Great Ormond Street Hospital;<\/p>
- University College London Hospital;<\/p>
- King\u2019s College Hospital;<\/p>
- University Hospitals Bristol NHS Trust;<\/p>
- The Christie NHS Foundation Trust;<\/p>
- Manchester Royal Infirmary;<\/p>
- Royal Manchester Children\u2019s Hospital;<\/p>
- Queen Elizabeth Hospital (Birmingham); and<\/p>
- Great Northern Children\u2019s Hospital (Newcastle).<\/p>
The following centres are able to provide CAR-T for adults with large B-cell lymphoma:<\/p>
- University College London Hospital;<\/p>
- King\u2019s College Hospital;<\/p>
- University Hospitals Bristol NHS Trust;<\/p>
- The Christie NHS Foundation Trust;<\/p>
- Manchester Royal Infirmary;<\/p>
- Queen Elizabeth Hospital Birmingham; and<\/p>
- Newcastle Hospitals NHS Foundation Trust.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"} } , "answeringMemberConstituency" : {"_value" : "South Ribble"} , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"} , "dateOfAnswer" : {"_value" : "2019-07-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-08T15:37:29.017Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-07-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Immunotherapy"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, which NHS trusts offer immunotherapy; and for which (a) indications and (b) ages of patient.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4657", "label" : {"_value" : "Biography information for Anneliese Dodds"} } , "tablingMemberConstituency" : {"_value" : "Oxford East"} , "tablingMemberPrinted" : [{"_value" : "Anneliese Dodds"} ], "uin" : "272294"} , {"_about" : "http://data.parliament.uk/resources/1136376", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1136376/answer", "answerText" : {"_value" : "
When an immunotherapy treatment has been approved by the National Institute for Health and Care Excellence (NICE), all relevant providers are required to implement NICE\u2019s guidance and make the treatment available for patients on the National Health Service.<\/p>
The NHS Long Term Plan sets out our commitment to making safer and more precise treatments, including advanced radiotherapy techniques and immunotherapies, available on the NHS to support improvements in survival rates.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"} } , "answeringMemberConstituency" : {"_value" : "South Ribble"} , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"} , "dateOfAnswer" : {"_value" : "2019-07-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-08T16:11:59.877Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-07-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Immunotherapy"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the availability of immunotherapy.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4657", "label" : {"_value" : "Biography information for Anneliese Dodds"} } , "tablingMemberConstituency" : {"_value" : "Oxford East"} , "tablingMemberPrinted" : [{"_value" : "Anneliese Dodds"} ], "uin" : "272295"} , {"_about" : "http://data.parliament.uk/resources/1136377", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1136377/answer", "answerText" : {"_value" : "
Availability of immunotherapy drugs happens via assessment at the National Institute for Health and Care Excellence (NICE). As they follow the same NICE process as other cancer medicines then all relevant providers are required to implement them in the same timelines as with any newly approved medicine.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"} } , "answeringMemberConstituency" : {"_value" : "South Ribble"} , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"} , "dateOfAnswer" : {"_value" : "2019-07-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-08T15:33:13.907Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-07-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Immunotherapy"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of whether the level of availability of immunotherapy is consistent with the objectives of the NHS Cancer Plan.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4657", "label" : {"_value" : "Biography information for Anneliese Dodds"} } , "tablingMemberConstituency" : {"_value" : "Oxford East"} , "tablingMemberPrinted" : [{"_value" : "Anneliese Dodds"} ], "uin" : "272296"} , {"_about" : "http://data.parliament.uk/resources/1128292", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1128292/answer", "answerText" : {"_value" : "
Each Primary Care Network (PCN) is required to appoint a Clinical Director who will take up their post formally from July 2019. Under the terms of the Network Contract Directed Enhanced Service (DES), PCNs can claim a funding contribution for this role. In 2019/20 this is a payment of £0.51430 per registered patient for the period 1 July 2019 to 31 March 2020.<\/p>
Practices will receive funding for participating in a PCN through the Network Participation Payment of £0.147 per weighted patient for the period from 1 April 2019. This becomes payable once they have signed up to the Network Contract DES and the DES commences, from 1 July 2019. In addition, once established, PCNs are entitled to funding of £0.125 per patient per month from clinical commissioning group (CCG) allocations, the first payment of which will cover the period 1 April to 31 July.<\/p>
Collectively, these funding streams and others mean PCNs receive £296 million in 2019/20. The Network Participation Payment and the clinical commissioning group PCN funding together reflect the additional work undertaken, including between 1 April and 30 June, to establish PCNs and appoint Clinical Directors.<\/p>
<\/p>
<\/strong><\/p> <\/strong><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-06-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-06-05T15:24:43.37Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-22", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "General Practitioners: Recruitment"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 May 2019 to Question 253711 on General Practitioners: Finance, from which sources GPs\u2019 surgeries can obtain funding for recruitment costs in the period before clinical directors take up their posts.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4657", "label" : {"_value" : "Biography information for Anneliese Dodds"}
}
, "tablingMemberConstituency" : {"_value" : "Oxford East"}
, "tablingMemberPrinted" : [{"_value" : "Anneliese Dodds"}
], "uin" : "257552"}
, {"_about" : "http://data.parliament.uk/resources/1126283", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1126283/answer", "answerText" : {"_value" : " My Rt. hon. Friend the Secretary of State has met with both Richard Vautrey and Helen Stokes-Lampard as representatives of the profession to discuss a range of issues, including, but not limited to, the creation of Primary Care Networks.<\/p> <\/p> In addition, Departmental officials have been in regular communication with both the Royal College of General Practitioners (RCGP) and the British Medical Association (BMA) throughout the development of the Primary Care Networks policy and will continue these close working relationships as the networks are implemented.<\/p> <\/p> The Primary Care Network Directed Enhanced Service specification, which sets out the timetable for networks, was agreed with the General Practitioners Committee and the BMA as part of negotiations on the contract for 2019/20.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-05-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-05-16T15:44:50.49Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Primary Care Networks"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions he had with (a) the British Medical Association, (b) the Royal College of General Practitioners and (c) other representative groups before announcing the timetable for the creation of primary care networks.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4657", "label" : {"_value" : "Biography information for Anneliese Dodds"}
}
, "tablingMemberConstituency" : {"_value" : "Oxford East"}
, "tablingMemberPrinted" : [{"_value" : "Anneliese Dodds"}
], "uin" : "253710"}
, {"_about" : "http://data.parliament.uk/resources/1126284", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1126284/answer", "answerText" : {"_value" : " Each Primary Care Network (PCN) is required to appoint a Clinical Director. Under the terms of the Network Contract Directed Enhanced Service (DES) contract specification published by NHS England in March 2019, PCNs can claim funding for this role. It is a population-based payment calculated using a baseline equivalent of 0.25 Whole Time Equivalent (WTE) per 50,000 registered population size, as at 1 January 2019 (one WTE being paid £137,516 in 2019/20). This is a payment of £0.51430 per registered patient for the period 1 July 2019 to 31 March 2020 (which equates to £0.057 per patient per month), reflecting the fact that the Network Contract DES begins in July 2019 - this will be the point at which the Clinical Directors take up their posts.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-05-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-05-16T15:49:49.05Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "General Practitioners: Finance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he has plans to allocate additional funding to GP practices to enable the recruitment and appointment of Primary Care Network medical directors.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4657", "label" : {"_value" : "Biography information for Anneliese Dodds"}
}
, "tablingMemberConstituency" : {"_value" : "Oxford East"}
, "tablingMemberPrinted" : [{"_value" : "Anneliese Dodds"}
], "uin" : "253711"}
, {"_about" : "http://data.parliament.uk/resources/1109022", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1109022/answer", "answerText" : {"_value" : " This is a matter for local clinical commissioning groups, and the information requested is not held centrally by the Department or NHS England.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-04-08", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-04-08T15:26:41.297Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-04-02", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Sterilisation"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how many Clinical Commissioning Groups commission vasectomy services for patients who are not in exceptional circumstances.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4657", "label" : {"_value" : "Biography information for Anneliese Dodds"}
}
, "tablingMemberConstituency" : {"_value" : "Oxford East"}
, "tablingMemberPrinted" : [{"_value" : "Anneliese Dodds"}
], "uin" : "240100"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 7, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}